![Wen Qing Liang](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Wen Qing Liang
Directeur Général chez CF PharmTech, Inc
Postes actifs de Wen Qing Liang
Sociétés | Poste | Début | Fin |
---|---|---|---|
CF PharmTech, Inc
![]() CF PharmTech, Inc Medical SpecialtiesHealth Technology CF PharmTech, Inc engages in the research, development, production and sale of respiratory diseases pharmaceutical products. It mainly involves in complex product & platform, innovative medicines, medical devices, & provide technical services. The company offers inhalers, asthma treatment products including Azelastine Hydrochloride and Fluticasone Propionate Nasal Spray. CF PharmTech was founded by Li LI in 2007 and is headquartered in Suzhou, China. | Directeur Général | 17/09/2020 | - |
Président | 17/09/2020 | - |
Historique de carrière de Wen Qing Liang
Formation de Wen Qing Liang
University of Massachusetts | Doctorate Degree |
Statistiques
Internationale
Chine | 2 |
Etats-Unis | 2 |
Opérationnelle
Chief Executive Officer | 1 |
Chairman | 1 |
Doctorate Degree | 1 |
Sectorielle
Health Technology | 2 |
Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Entreprise privées | 1 |
---|---|
CF PharmTech, Inc
![]() CF PharmTech, Inc Medical SpecialtiesHealth Technology CF PharmTech, Inc engages in the research, development, production and sale of respiratory diseases pharmaceutical products. It mainly involves in complex product & platform, innovative medicines, medical devices, & provide technical services. The company offers inhalers, asthma treatment products including Azelastine Hydrochloride and Fluticasone Propionate Nasal Spray. CF PharmTech was founded by Li LI in 2007 and is headquartered in Suzhou, China. | Health Technology |
- Bourse
- Insiders
- Wen Qing Liang
- Expérience